MAPT and Alzheimer disease: In particular, the levels of total Aβ (p < .0001, Figure 2a), soluble tau (p < .0001, Figure 2b), and insoluble tau (p < .0001, Figure 2c) were significantly higher in AD cases (Figure 2, Table 2).